Indian firms may garner up to 50% of USFDA nod share in 2023
NEW DELHI: Indian companies are expected to secure a 48-50 percent share of approvals for new drugs from the US ...
©2024 Blitz India Media -Building A New Nation
Tag: Indian companies
Recent News
NITI Aayog launches Special Campaign 6.0
Blitz Bureau New Delhi, 28 September: NITI Aayog has introduced a ‘Special Campaign 6.0’, while disposing of more than 4,100...
Read moreDetails